Position in HROW
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$322,602
New position
Shares Held
7,596
first reported quarter
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#127
of 221 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Beacon Pointe Advisors, LLC holds $8,967,687 across 9 Drug Manufacturers - Specialty & Generic names. HROW ranks #4 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
82,642 | $5,938,654 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,389 | $1,294,431 | |
| 3 | VTRS |
Viatris Inc
|
31,509 | $500,362 | |
| 4 | HROW |
Harrow, Inc.
This page
|
7,596 | $322,602 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
16,724 | $268,085 | |
| 6 | HLN |
Haleon plc
|
27,933 | $260,614 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
60,500 | $251,680 | |
| 8 | TRLV |
Trulieve Cannabis Corp.
|
10,651 | $104,699 |
All Filings in HROW
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $322,602 | 7,596 | Shares | Sole | 2026-08-18 | |
| No filing history on record for this holder in this stock. | ||||||